EPIC-DB: a proteomics database for studying Apicomplexan organisms by Madrid-Aliste, Carlos J et al.
BioMed  Central
Page 1 of 7
(page number not for citation purposes)
BMC Genomics
Open Access Database
EPIC-DB: a proteomics database for studying Apicomplexan 
organisms
Carlos J Madrid-Aliste1,2,3, Joseph M Dybas1,2,3, Ruth Hogue Angeletti1,2,5,8, 
L o u i sMW e i s s 1,4,6, Kami Kim1,6,7, Istvan Simon10 and Andras Fiser*1,2,3,9
Address: 1Biodefense Proteomics Research Center, Albert Einstein College of Medicine, 1300 Morris Park Avenue, Bronx, NY 10461, USA, 
2Department of Systems and Computational Biology, Albert Einstein College of Medicine, 1300 Morris Park Avenue, Bronx, NY 10461, USA, 
3Department of Biochemistry, Albert Einstein College of Medicine, 1300 Morris Park Avenue, Bronx, NY 10461, USA, 4Department of Pathology, 
Albert Einstein College of Medicine, 1300 Morris Park Avenue, Bronx, NY 10461, USA, 5Department of Developmental and Molecular Biology, 
Albert Einstein College of Medicine, 1300 Morris Park Avenue, Bronx, NY 10461, USA, 6Department of Medicine, Albert Einstein College of 
Medicine, 1300 Morris Park Avenue, Bronx, NY 10461, USA, 7Department of Microbiology and Immunology, Albert Einstein College of Medicine, 
1300 Morris Park Avenue, Bronx, NY 10461, USA, 8Laboratory for Macromolecular Analysis and Proteomics, Albert Einstein College of Medicine, 
1300 Morris Park Avenue, Bronx, NY 10461, USA, 9Albert Einstein College of Medicine, 1300 Morris Park Avenue, Bronx, NY 10461, USA and 
10Institute of Enzymology, Hungarian Academy of Sciences, Karolina ut 29, Budapest 1113, Hungary
Email: Carlos J Madrid-Aliste - cmadrid@fiserlab.org; Joseph M Dybas - joe@fiserlab.org; Ruth Hogue Angeletti - angelett@aecom.yu.edu; 
Louis M Weiss - lmweiss@aecom.yu.edu; Kami Kim - kkim@aecom.yu.edu; Istvan Simon - simon@enzim.hu; 
Andras Fiser* - afiser@aecom.yu.edu
* Corresponding author    
Abstract
Background: High throughput proteomics experiments are useful for analyzing the protein expression
of an organism, identifying the correct gene structure of a genome, or locating possible post-translational
modifications within proteins. High throughput methods necessitate publicly accessible and easily queried
databases for efficiently and logically storing, displaying, and analyzing the large volume of data.
Description: EPICDB is a publicly accessible, queryable, relational database that organizes and displays
experimental, high throughput proteomics data for Toxoplasma gondii and Cryptosporidium parvum. Along
with detailed information on mass spectrometry experiments, the database also provides antibody
experimental results and analysis of functional annotations, comparative genomics, and aligned expressed
sequence tag (EST) and genomic open reading frame (ORF) sequences. The database contains all available
alternative gene datasets for each organism, which comprises a complete theoretical proteome for the
respective organism, and all data is referenced to these sequences. The database is structured around
clusters of protein sequences, which allows for the evaluation of redundancy, protein prediction
discrepancies, and possible splice variants. The database can be expanded to include genomes of other
organisms for which proteome-wide experimental data are available.
Conclusion: EPICDB is a comprehensive database of genome-wide T. gondii and C. parvum proteomics
data and incorporates many features that allow for the analysis of the entire proteomes and/or annotation
of specific protein sequences. EPICDB is complementary to other -genomics- databases of these organisms
by offering complete mass spectrometry analysis on a comprehensive set of all available protein sequences.
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Background
High throughput proteomics experiments (mass spec-
trometry) provide unique insight into the protein expres-
sion profile of an organism and can be useful in
identifying the correct gene structure of a genome, partic-
ularly when splice variants or alternative gene predictions
exist, or to elucidate the roles of post-translational modi-
fications within proteins [1]. Indeed, large scale proteom-
ics approaches have been used in recent years to analyze
genomes of various organisms such as S. cerevisiae [2], M.
mobile [3], C. parvum [4], T. gondii [5], and S. luteogriseus
[6], as well as various subproteomes [7-9]. Recent
advances in high throughput methods as well as the
increased emphasis on and amount of high throughput
data necessitate publicly accessible and easily queried
databases for efficiently storing, displaying, and analyzing
the large volume of data. We have established a proteom-
ics database, EPICDB (Experimental ProteomICs Data-
base) to accommodate experimental data from the large-
scale proteomics exploration of two Apicomplexan organ-
isms; Toxoplasma gondii and Cryptosporidium parvum.
T. gondii is an obligate intracellular protozoan, belonging
to the phylum Apicomplexa, and is an important patho-
gen in both immune competent and immune compro-
mised humans. The parasite causes chronic infection in
adults and is present in an estimated 22.5% of people
older than 12 in the United States [10] and up to 90% of
the population in other regions of the world [11]. T. gondii
clinical disease is most typical in immune compromised
individuals and congenitally infected children and is a
common opportunistic pathogen associated with AIDS.
Also, T. gondii is an important model system for the phy-
lum Apicomplexa [12], which includes, among others,
Plasmodium (malaria) species. Unlike many other Api-
complexa, which are experimentally intractable, T. gondii
is easily cultured in vitro, has well established experimen-
tal protocols for genetic manipulation, and has a well
characterized mouse model [13]. Cryptosporidium parvum
is an Apicomplexan parasite that infects the epithelial cells
of the microvillus border of the gastrointestinal tract
where it resides in a unique vacuole bellow the host cell
membrane but outside the host cell cytoplasm [14]. This
organism forms resistant oocysts which are transmitted
effectively by food or water. Ingestion of these oocysts
results in infection of the gastrointestinal track with the
development of diarrhea, which can be profuse especially
in immune compromised hosts. Unlike T. gondii, in vitro
culture is difficult and there are no established experimen-
tal protocols for genetic manipulation. Due to waterborne
outbreaks associated with T. gondii [15] and C. parvum
[16], these organisms are classified by the National Insti-
tute of Allergy and Infectious Diseases as Category B pri-
ority pathogens.
EPICDB contains high throughput mass spectrometry
data that is cross referenced to all available computation-
ally and experimentally derived protein sequences for T.
gondii and C. parvum. The database can be queried to find
proteins that are experimentally verified by proteomics
data and, in doing, can aid in the discovery of sequences
that have not been fully annotated but are supported by
experimental data. Further, since all the proteomics data
are comprehensively searched against all available protein
sequences, EPICDB is a good resource for assessing dis-
crepancies among sequences predicted by different algo-
rithms and for examining splice variants of the same gene.
Additionally, the format is suitable to accommodate addi-
tional experimental data or other organisms and can be
used as a model system for other genomes for which high
throughput proteomics data will become available.
The primary focus of EPICDB is to provide a comprehen-
sive proteome-based description of the selected patho-
gens. This distinguishes it from other, genome-based
databases, which exist for various apicomplexan and
other organisms, such as, for example, ToxoDB http://
www.toxodb.org, CryptoDB http://www.cryptodb.org, or
TrichDB http://www.trichdb.org.
Construction and content
Database construction
EPICDB is a relational database using a MySQL database
management system and consisting of 40 tables. Within
the database, query-response time is optimized by reading
a summary table containing the results of a complex
"JOIN" query.
The CGI::Application http://cgi-app.org/ framework was
used for the web application development. CGI::Applica-
tion is a stable and lightweight open source framework for
building web-applications on any operating system that
supports Perl and CGI. It encourages developers to adopt
a model-view-controller (MVC) architecture, which sepa-
rates the application logic that interacts with a database
(model) from the HTML pages presented to the client
(view) and the user input actions (controller). At the front
end, HTML pages, CSS files, and Javascript code are imple-
mented using a template system (HTML::Template).
Database content
EPICDB is a collection of experimental and computa-
tional data that are referenced to all available protein
sequences for T. gondii and C. parvum, which represent the
theoretical proteomes of the respective organisms. The
available T. gondii protein sequences were compiled from
five datasets; TigrScan [17], TwinScan [18], Glimmer-
HMM [17], ToxoDB.org Release4, and experimental
sequences from the NCBI protein databases. TigrScan,
TwinScan, and GlimmerHMM are computational geneBMC Genomics 2009, 10:38 http://www.biomedcentral.com/1471-2164/10/38
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finder algorithms that were employed by The Institute for
Genomic Research (now the J. Craig Venter Institute) on
the ME49 strain of T. gondii. The Release4 dataset is an
annotation of the ME49 strain with sequences predicted
by the GLEAN [19] algorithm. The dataset of experimental
sequences was obtained from the NCBI Entrez Protein
Database, which was filtered, by the organism name, for
Toxoplasma gondii (As of July 2008, predicted genes/pro-
teins from T. gondii genome analysis have not been depos-
ited to NCBI or GenBank databases). The five datasets
were combined to provide a comprehensive set of all
available protein sequences for the Toxoplasma gondii pro-
teome and comprised 30,197 sequences. While T. gondii
has an intron rich genome and, consequently, presents
substantial difficulty for gene prediction programs to
properly identify gene coding regions, in C. parvum there
are almost no introns and gene prediction is rather
straightforward [20]. The available C. parvum sequences
were obtained from CryptoDB http://www.cryptodb.org
and from the NCBI Entrez Protein Database, which was
filtered, by the organism name, for Cryptosporidium Par-
vum. The combined C. parvum dataset comprises 8,316
protein sequences. In the case of both organisms the
sequence sets are redundant due to computational algo-
rithms predicting the same (or essentially same)
sequences or the same sequences appearing more than
once as experimentally derived sequences in the NCBI
database.
Because of the redundancy among the alternate gene
models, the database is organized in clusters of the pro-
tein sequences that share at least 90% sequence identity
for the overlapping parts [21]. Clustering allows the user
to evaluate redundancy or prediction differences among
different sequences. However, since the clustering scheme
allows sequences to be grouped if they share local
sequence similarity and not only sequences that are exact
matches for the entire length, in many cases, clustering
also offers the possibility of exploring alternative splicing
events in the genome, when proteins are predicted from
the same genomic location and differ by the inclusion,
exclusion, elongation, or truncation of some introns or
exons. The T. gondii dataset contains 30,197 alternative
protein sequences, or possible splice variants, that are
clustered into 14,983 groups of sequences, or possible
protein coding genomic regions. The C. parvum dataset
contains 8,316 sequences that are clustered into 3,852
groups.
EPICDB currently contains the results of 183 high
throughput, tandem mass spectrometry experiments that
were performed on T. gondii plasma membrane, cytoskel-
etal, cyst wall, and cytosolic protein preparations. These
experiments produced 33,045 proteolytic peptides that,
when searched against a database of the T. gondii protein
sequences, experimentally verified 8,372 sequences (that
can be grouped into 3,233 clusters). Further, EPICDB con-
tains data from 88 high throughput, tandem mass spec-
trometry experiments that were performed on C. parvum.
These experiments produced 3,049 proteolytic peptides
that experimentally verified 1,241 C. parvum protein
sequences (481 clusters). The data contained within
EPICDB is a comprehensive summary of the mass spec-
trometry experiments and the MASCOT http://
www.matrixscience.com searches of the data against the
theoretical proteomes. For each protein, a list of the exper-
iments that identified a proteolytic peptide that maps to
that protein is included, along with the type of cell frac-
tion analyzed, the type of mass spectrometry experiment
conducted, and the number of peptide hits that were
obtained. The mass spectrometry data and the results of
the MASCOT search are provided and publicly available
in five formats; CSV (comma separated value) formatted
mass spectrometry files, RAW unformatted mass spec-
trometry data files, MGF (MASCOT Generic Format) and
DTA files, containing peak lists of mass and intensity val-
ues, and MASCOT search summary files. Data for peptide
scores, expectation values, location in the protein, and
protein coverages are included for each proteolytic pep-
tide that is mapped to the protein.
As an example of the addition of other types of experi-
mental data, EPICDB also currently stores the results of
antibody experiments that were performed on 52 T. gondii
and 34 C. parvum protein sequences, including informa-
tion on the peptide sequences used for immunization in
the production of the antibodies, the amount of sera pro-
duced for each peptide mixture, and the results of
Enzyme-Linked ImmunoSorbent Assays (ELISA),
Immuno-Fluorescence Assays (IFA), and Immunoblot
experiments, with images if available.
Additional mass spectrometry and antibody experiments
are being continuously performed by the Albert Einstein
Biodefense Proteomics Research Center and the results are
incrementally added to EPICDB.
EPICDB contains functional annotations and compara-
tive genomics for the theoretical proteomes of T. gondii
and C. parvum. Transmembrane segments and signal pep-
tides were predicted using the Phobius program [22]. All
known PFAM domains [23] were also identified. For each
sequence in EPICDB, orthologous proteins were identi-
fied from sequences in the human genome, in other Api-
complexan genomes, and for the complete NCBI non-
redundant protein database. Aligned genomic data
(cDNA (ESTs) and ORFs) are also presented for each T.
gondii  protein sequence within the database. EST
sequences were obtained from the NCBI EST "others"
database and filtered for the organism name. ORFBMC Genomics 2009, 10:38 http://www.biomedcentral.com/1471-2164/10/38
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sequence data was obtained from ToxoDB.org version
Release4. All experimental details and analysis of how
mass spectrometry peptide hits validate alternative gene
predictions can be found in a separate research article (J.
Dybas et al. Computational Analysis and Experimental
Validation of Gene Predictions in Toxoplasma gondii
PLOSone. 2008;3(12):e3899. Epub 2008).
Utility and discussion
Querying the database
EPICDB is accessed through a query front-page where the
user can define conditions for searching the underlying
relational database (Figure 1). The minimum parameter
that must be set is the type of genome to be searched
(Organism). If no other parameters are specified all possi-
ble protein sequences will be listed and clustered.
The database can be queried in a variety of ways. The
Experimental Characterization query option selects the sub-
set of protein sequences that are experimentally validated
by mass spectrometry and/or antibody data. For the mass
spectrometry experiments it is possible to select a subset
of proteins based on the type of experimental cell fraction,
such as membrane, cytosolic, or deglycosylated cell wall.
The Annotations query is used to search for those proteins
that are functionally characterized in terms of transmem-
brane domains, signal peptides and/or Pfam domains.
Within the Pfam domains, it is possible to search by a spe-
cific domain name, such as "ACC_central", or by a
description such as "Acetyl-CoA". The Comparative Genom-
ics query locates predicted proteins that share a detectable
sequence similarity (based on a BLAST search [24]) with
other Apicomplexan genomes, with the human genome,
or with any known proteins (referencing against the com-
plete NCBI non-redundant protein database). Annota-
tions from similar proteins are inherited and stored for
each EPICDB protein sequence and the database search
can be refined by a search for specific keywords, such as
"transporter". Any or all of the aforementioned parame-
ters can be selected to be combined in a single query.
In addition to seeing the query results for the entire theo-
retical genome, the Gene Predictions and Experimental Data-
sets query allows for the selection of proteins based on the
type of gene prediction method or by only experimentally
derived proteins. Within this query option one can search
the database for a specific gene name, such as
"TgTigrScan_1043".
Rather than querying the database based on experimental
characteristics, it is possible to perform a BLAST search for
a user-input protein sequence, or sequence fragment,
against the entire EPICDB. The sensitivity of the BLAST
search can be adjusted by defining the corresponding e-
value cutoff.
Parsing the query results
The results page (Figure 2) displays the clusters of
sequences where at least one of the cluster members
matches the user-defined query. The top of the query
results page lists the number of sequences that match the
query criteria, the number of clusters that those sequences
belong to, and the number of all the sequences within the
matching clusters.
The query results table lists the protein sequences and a
summary of their corresponding experimental and com-
putational data. The header of the results table displays
the search parameters that were used to query the data-
base. The clusters of proteins are listed and the sequences
are displayed using the unique identifiers that were
assigned by the prediction algorithms. A green dot next to
a sequence indicates that the sequence matched the query
criteria. To the left of each cluster there is a link to access
an image that shows the aligned protein sequences in the
cluster with any mapped mass spectrometry proteolytic
Screenshot of the EPICDB query front page Figure 1
Screenshot of the EPICDB query front page. This page 
is where the user chooses the organism to be studied and 
queries the database for "Experimental Characterizations", 
"Annotations", "Comparative Genomics", or "Gene predic-
tions and experimental datasets" or searches the database 
for a specific sequence.BMC Genomics 2009, 10:38 http://www.biomedcentral.com/1471-2164/10/38
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peptides along with any aligned EST and ORF sequences
(Figure 3). The sequence length is provided for each
sequence. In the subsequent columns, to the right of each
protein sequence, a check-mark indicates the presence of
information on mass spectrometry experiments, antibody
production experiments, EST alignments, functional
annotations (PFAM domains, transmembrane segments,
and signal peptides), or comparative genomics (orthologs
found in an Apicomplexan genome, human genome, or
the NCBI protein database) for that sequence. Clicking on
the checkmark navigates to a subpage where the specific
information for that data-type is displayed.
Viewing experimental and computational data
If a specific protein or data-type is selected a protein spe-
cific page is displayed with a header containing four
options; Mapping, Annotations, MassSpec and Antibody. The
Mapping page (the default destination when a protein is
selected) displays the protein sequence length, the actual
amino acid sequence, and information on any ortholo-
gous proteins in other databases. The Annotation page pro-
vides a graphical display of the protein sequence and any
predicted transmembrane segments, signal peptides, or
PFAM domains and, optionally, more specific data for
each of the annotation features. The MassSpec page (Figure
4) begins with a list of all experiments that identified a rel-
evant proteolytic peptide that maps to the selected pro-
tein, along with the type of cell fraction analyzed, the type
of mass spectrometry experiment conducted, and the
number of peptide hits for the experiment. The mass spec-
trometry and MASCOT data files (see Database Content)
are available in this table. In the section below, the iden-
tified proteolytic peptides are mapped on the protein
sequence using a color coding scheme that indicates the
confidence (MASCOT peptide score) of each peptide.
Finally, a more comprehensive analysis of each mass spec-
trometry experiment is displayed, which includes the pro-
tein total coverage by the identified peptides, and the
peptide score, expectation value, sequence, and location
in the protein, for each identified peptide. The Antibody
page displays information on antibody production data as
well as the sequence of the antibody, the amounts of the
sera in different animals, and ELISA, IFA, and Immunob-
lot experimental results, with images where available.
Finding help
Most options in the query page contain a link to a help
page with a brief description of the specific parameter or
option and, where applicable, a link to an associated web
page. In addition, most navigating options, category head-
ings, and table titles, on the query page, results page, and
data pages contain pin-point helps providing a brief
Screenshot of the query results page Figure 2
Screenshot of the query results page. The sequence 
clusters that contain a protein matching the user-defined 
query are displayed along with a summary of their corre-
sponding experimental and computational data.
Sequence cluster image Figure 3
Sequence cluster image. The cluster image showing a 
cluster of protein sequences (red line) and assigned mass 
spectrometry peptides (black boxes on protein sequences). 
Below the protein sequences are the aligned ESTs (blue lines 
with directionality indicated) and ORFs (black lines). A 
unique identifier is included for each protein, EST, and ORF 
sequence.BMC Genomics 2009, 10:38 http://www.biomedcentral.com/1471-2164/10/38
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explanation of that entity. The upper right corner of the
front (query) page has a link to three Flash formatted
video tutorials that describe the options for querying the
database and for understanding the query results page and
the various data pages.
Discussion
All available protein sequences for T. gondii and C. parvum
that emerged from various gene prediction approaches or
were experimentally derived are compiled into a hypo-
thetical proteomes for each of the respective organisms in
order to be able to search the proteomics data with the
most comprehensive and unbiased dataset possible.
Therefore, while some redundancy is obviously intro-
duced, it also allows for the experimental verification and,
potentially, the added scrutiny and study of many more
sequences than what would be possible if only one set of
protein predictions were adequately searched with the
proteomics data.
EPICDB's functionality provides the options for a sys-
tems-level analysis as well as specific protein-level analy-
sis. The proteome can be searched for any sequences that
have experimental validation. Subsets of sequences can be
found for those containing desired characteristics such as
functional annotations or comparative genomics. Thus,
the proteome can be studied by isolating specific sets of
sequences that are of unique interest to the user. Within
the obtained sequence sets, individual sequences can be
analyzed. The individual sequence can be compared to
similar sequences, via the clustering analysis, to determine
any possible splice variability of the protein or instances
in which there are disparities in the sequence predictions.
Proteomics data can be analyzed to assess the validity of
the predictions and/or splice variants by studying the dis-
tribution of assigned peptides on the amino acid
sequence. In some cases a mass spectrometry peptide can
indicate the possibility of an additional exon or the pres-
ence of incorrect splicing. Finally, EPICDB allows for the
user to enter an amino acid sequence of interest and find
any similar sequences in the database. This functionality
provides the opportunity to examine any experimental
evidence for a specific gene that the user is attempting to
study and characterize.
At the present time the types of data contained within
EPICDB are mass spectrometry and antibody experi-
ments, EST and ORF sequences, functional annotations,
and comparative genomics. However, the database can be
easily expanded. We are currently planning to integrate
genome-wide microarray expression data and ChIP-on-
chip data into the database. Also, with little effort, other
genomes can be added to the system.
While EPICDB provides a variety of automated annota-
tions and all validation information, one of the major
challenges is to properly annotate and analyze predicted
genes and proteins on an individual basis. This type of
work is best approached by a community effort where var-
ious groups have specific areas of expertise, perhaps
regarding a specific protein or groups of proteins. There-
fore we plan to establish a wiki-like option so experts can
add information on annotations or functions of proteins.
Conclusion
High throughput mass spectrometry data has a variety of
important applications to genomics and proteomics. Vast
amount of genomic sequence data with comparatively
small amounts of experimentally derived protein
sequence data necessitate the need for computational
gene finders and high throughput mass spectrometry data
Screenshot of the "MassSpec" data page Figure 4
Screenshot of the "MassSpec" data page. The mass 
spectrometry data page contains the data corresponding to 
all of the mass spectrometry experiments that contained a 
mass spectrometry peptide that was assigned to the respec-
tive protein.Publish with BioMed Central    and   every 
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can inform and support these predictions. High through-
put mass spectrometry is an emerging efficient method
toward a comprehensive, proteome-wide analysis of an
organism, which is an important step in identifying pro-
tein interactions, studying protein expression levels, eluci-
dating alternative splice sites, or predicting potential
chemotherapeutic targets. EPICDB is a comprehensive
database for organizing, querying, and displaying pro-
teome-wide proteomics data and incorporates many fea-
tures that allow for the analysis of the entire proteomes
and/or annotation of specific protein sequences for char-
acterizing the proteomes of T. gondii and C. parvum.
Availability and requirements
EPICDB can be accessed by the website http://www.fiser
lab.org/epicdb. The database and all data is publicly avail-
able. There are, on average, 6 unique users per day (statis-
tics do not count access from Albert Einstein College of
Medicine computers) and 36.4 Mb of data transferred.
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